Skip to main content
VCbacked
Log inGet Started

Novamigra Therapeutics

Budapest, Hungary

Novamigra Therapeutics is a biotechnology research organisation engaged in advancing a novel approach to migraine prophylaxis.

$3.5M raised
Jan 2026
Venture - Series Unknown
BiopharmaBiotechnologyLife SciencePharmaceutical

Top Investors

SZTAPMK VenturesThe Vascular Group

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Novamigra Therapeutics

How much funding has Novamigra Therapeutics raised?
Novamigra Therapeutics has raised $3.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2026.
Who are Novamigra Therapeutics's investors?
Novamigra Therapeutics's investors include SZTA, PMK Ventures, The Vascular Group.
Where is Novamigra Therapeutics headquartered?
Novamigra Therapeutics is headquartered in Budapest, Hungary.
What does Novamigra Therapeutics do?
Novamigra Therapeutics is a biotechnology research organisation engaged in advancing a novel approach to migraine prophylaxis.
What stage is Novamigra Therapeutics at?
Novamigra Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Novamigra Therapeutics — Funding & Investors." VCBacked, January 9, 2026, https://www.vcbacked.co/company/novamigra-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2026). Novamigra Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/novamigra-therapeutics
Wikipedia (cite web)
{{cite web |title=Novamigra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/novamigra-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego